Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous peramivir for experimental influenza
2007-004660-47Phase 2Terminated
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- Oct 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in influenza comparing Peramivir 400 mg IV with Placebo IV (2 arms). Primary endpoint: Virologic activity. Started Oct 2007; status: terminated.
02
Drugs
peramivir
03
Conditions
influenza
Beyond the preview
Go deeper on 2007-004660-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004660-47.